Return to program book search
Tuesday, March 05
10:00 AM - 12:00 PM
James Selwyn Taylor, MD, FAAD
- David R. Adams, MD, PharmD, FAAD - Handout
- Karen E. Edison, MD, FAAD
- Hillary Johnson-Jahangir, MD, PhD, FAAD
- Mario E. Lacouture, MD, FAAD
- Patrick E. McCleskey, MD, FAAD - Handout
Following this course, the attendee should be able to:
- 1. Develop improved outcomes though better patient education and analyze essential therapeutic safety issues in procedural dermatology, including perioperative safety and adverse effects of topical anesthetics.
- 2. Evaluate current guidelines for methotrexate therapy and the newer approaches to prevent chemotherapy-induced skin reactions.
- 3. Examine your own practice to identify those therapeutic safety principles which you can improve or implement tomorrow
We will discuss important therapeutic safety issues in medical and procedural dermatology including general concepts and specific topics. Direct patient engagement in therapeutic decisions and better health literacy will improve outcomes. Therapeutic safety issues in procedural dermatology include patient misidentification, wrong site surgery, use of photographs, medication errors and sharps injuries. Factors associated with increased cutaneous and systemic toxicity after application of topical anesthetics will be reviewed. Current methotrexate guidelines will be discussed followed by a review of the new field of supportive oncodermatology and preventing adverse events to cancer therapy. Time for questions is included after each presentation.
|Tuesday, March 05|
|10:00 AM||Introduction / Dr. Taylor|
|10:02 AM||Educate Your Patient and Improve Outcomes: Health Literacy for Dermatologists / Dr. Edison|
|10:30 AM||Therapeutic Safety: Procedural Dermatology / Dr. Johnson-Jahangir|
|10:55 AM||Comfortably Numb: Topical Anesthesia Risks and Guidelines / Dr. McCleskey|
|11:15 AM||Methotrexate Guidelines / Dr. Adams|
|11:35 AM||Oncodermatology: Preventive Measures for Chemotherapy-Induced Skin Reactions / Dr. Lacouture|